Trial Profile
Retrospective, Real-life Observational, Matched Cohort Evaluation of the Effectiveness of BDP/FOR (Fostair 100/6) and FP/SAL (Seretide 125) in Patients Switching From Seretide to Fostair in UK Primary Care Asthma Management.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2012
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 07 Jun 2012 Actual patient number is 137 according to ClinicalTrials.gov.
- 07 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2011 Planned end date changed from 1 Mar 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.